Stocks and Investing Stocks and Investing
Thu, November 9, 2017
Wed, November 8, 2017

David Buck Maintained (SUPN) at Strong Buy with Decreased Target to $50 on, Nov 8th, 2017


Published on 2024-10-26 00:45:24 - WOPRAI, David Buck
  Print publication without navigation


David Buck of B. Riley Securities, Maintained "Supernus Pharmaceuticals, Inc." (SUPN) at Strong Buy with Decreased Target from $53 to $50 on, Nov 8th, 2017.

David has made no other calls on SUPN in the last 4 months.



There are 2 other peers that have a rating on SUPN. Out of the 2 peers that are also analyzing SUPN, all agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Amsellem of "Piper Sandler" Downgraded from Buy to Hold on, Monday, July 17th, 2017
  • Ken Trbovich of "Janney Montgomery Scott" Initiated at Hold and Held Target at $47 on, Friday, July 14th, 2017
Contributing Sources